‌

US Patent 11434247 Substituted furanopyrimidine compounds as PDE1 inhibitors

Patent 11434247 was granted and assigned to Dart Neuroscience Llc on September, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Dart Neuroscience Llc

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11434247

Date of Patent

September 6, 2022

Patent Application Number

16766258

Date Filed

November 26, 2018

Patent Citations Received

‌

US Patent 11999738 Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors

‌

US Patent 12006325 Substituted furanopyrimidine compounds as PDE1 inhibitors

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11434247 Substituted furanopyrimidine compounds as PDE1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API